Literature DB >> 8232556

BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription.

P A Khavari1, C L Peterson, J W Tamkun, D B Mendel, G R Crabtree.   

Abstract

Sequence-specific DNA binding activators of gene transcription may be assisted by SWI2 (SNF2), which contains a DNA-dependent ATPase domain. We have isolated a human complementary DNA encoding a 205K nuclear protein, BRG1, that contains extensive homology to SWI2 and Drosophila brahma. We report here that a SWI2/BRG1 chimera with the DNA-dependent ATPase domain replaced by corresponding human sequence restored normal mitotic growth and capacity for transcriptional activation to swi2- yeast cells. Point mutation of the conserved ATP binding site lysine abolished this complementation. This mutation in SWI2 exerted a dominant negative effect on transcription in yeast. A lysine to arginine substitution at the corresponding residue of BRG1 also generated a transcriptional dominant negative in human cells. BRG1 is exclusively nuclear and present in a high M(r) complex of about 2 x 10(6). These results show that the SWI2 family DNA-dependent ATPase domain has functional conservation between yeast and humans and suggest that a SWI/SNF protein complex is required for the activation of selective mammalian genes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8232556     DOI: 10.1038/366170a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  256 in total

1.  A family of chromatin remodeling factors related to Williams syndrome transcription factor.

Authors:  D A Bochar; J Savard; W Wang; D W Lafleur; P Moore; J Côté; R Shiekhattar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 2.  ATP-dependent chromatin-remodeling complexes.

Authors:  M Vignali; A H Hassan; K E Neely; J L Workman
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Targeting a SWI/SNF-related chromatin remodeling complex to the beta-globin promoter in erythroid cells.

Authors:  C H Lee; M R Murphy; J S Lee; J H Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Stable remodeling of tailless nucleosomes by the human SWI-SNF complex.

Authors:  J R Guyon; G J Narlikar; S Sif; R E Kingston
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

5.  The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation.

Authors:  N Barker; A Hurlstone; H Musisi; A Miles; M Bienz; H Clevers
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

6.  ERAP140, a conserved tissue-specific nuclear receptor coactivator.

Authors:  Wenlin Shao; Shlomit Halachmi; Myles Brown
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

7.  Octamer transfer and creation of stably remodeled nucleosomes by human SWI-SNF and its isolated ATPases.

Authors:  M L Phelan; G R Schnitzler; R E Kingston
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

8.  Elucidation of the functional roles of the Q and I motifs in the human chromatin-remodeling enzyme BRG1.

Authors:  Helen Hoffmeister; Andreas Fuchs; Laura Strobl; Frank Sprenger; Regina Gröbner-Ferreira; Stefanie Michaelis; Petra Hoffmann; Julian Nazet; Rainer Merkl; Gernot Längst
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

Review 9.  Nuclear organization mediates cancer-compromised genetic and epigenetic control.

Authors:  Sayyed K Zaidi; Andrew J Fritz; Kirsten M Tracy; Jonathan A Gordon; Coralee E Tye; Joseph Boyd; Andre J Van Wijnen; Jeffrey A Nickerson; Antony N Imbalzano; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  Adv Biol Regul       Date:  2018-05-09

10.  Brahma regulates a specific trans-splicing event at the mod(mdg4) locus of Drosophila melanogaster.

Authors:  Simei Yu; Johan Waldholm; Stefanie Böhm; Neus Visa
Journal:  RNA Biol       Date:  2014-02-06       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.